Seismic Therapeutic, Inc.

Watertown, MA · Founded 2020 · CIK 0002002995 · Biotech · Private

Machine learning-designed biologic medicines for autoimmune and inflammatory diseases

seismictx.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$121M
1 Form D · Dec 2023
34 months since last filing
Contracts
—
No federal contracts on record
Patents
40
3 granted · 37 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$121,279,929
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2804ANSA BIOTECHNOLOGIES, INC.—$123M
2805Frontier Medicines—$122M
2806Praxis Precision Medicine——
2807Seismic Therapeutic, Inc.—$121M
2808TRIM-EDICINE INC——
2809Orna Therapeutics Holdings, LLC—$121M
2810Edgewise Therapeutics—$120M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 7 related persons
  • Shelley ChuDirector
  • Alan CraneDirector
  • Julie EastlandDirector
  • Edward FreedmanExecutive Officer
  • Andrew HedinDirector
  • Timothy SpringerDirector
  • Joanne VineyDirector · Executive Officer

Patents

USPTO · 3 granted of 40
  • VARIANT IgG FC POLYPEPTIDES AND USES THEREOFapplication
  • IgE PROTEASES AND USES THEREOFapplication
  • VARIANT IgG FC POLYPEPTIDES AND USES THEREOFapplication
  • Protease Variants And Uses Thereofapplication
  • Fc Fusion Molecules And Uses Thereofapplication
  • Molecules For Modulating The Immune System And Uses Thereofapplication
  • Protease Variants And Uses Thereofgranted
  • Fc Fusion Molecules And Uses Thereofgranted
  • VARIANT IgG FC POLYPEPTIDES AND USES THEREOFgranted
  • Dual Targeted Immune Regulating Compositionsapplication
  • Dual Targeted Immune Regulating Compositionsapplication
  • Systems And Methods For Predicting B-cell Epitopesapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.